TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive In Brief: Over Half Of Ovarian Cancer Patients Staged Incorrectly; Senate Gets Funding Resolution April 12, 1985